Cargando…

Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019

OBJECTIVE: Describe the characteristics of the therapeutic positioning reports (TPRs) published in Spain in the period 2013-2019. DESIGN AND DATA SOURCE: Systematic review of all TPRs published in the website of the Spanish Agency of Medicines and Health Products (AEMPS). SELECTION OF STUDIES: All T...

Descripción completa

Detalles Bibliográficos
Autores principales: García, Verónica, Corbalán, Laura, Baquero, Sandra, García-Esquinas, Esther, Sacristán, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054275/
https://www.ncbi.nlm.nih.gov/pubmed/32376055
http://dx.doi.org/10.1016/j.aprim.2020.02.012
_version_ 1783680268225216512
author García, Verónica
Corbalán, Laura
Baquero, Sandra
García-Esquinas, Esther
Sacristán, José Antonio
author_facet García, Verónica
Corbalán, Laura
Baquero, Sandra
García-Esquinas, Esther
Sacristán, José Antonio
author_sort García, Verónica
collection PubMed
description OBJECTIVE: Describe the characteristics of the therapeutic positioning reports (TPRs) published in Spain in the period 2013-2019. DESIGN AND DATA SOURCE: Systematic review of all TPRs published in the website of the Spanish Agency of Medicines and Health Products (AEMPS). SELECTION OF STUDIES: All TPRs published since May 2013, until March 2019 DATA EXTRACTION: The main variables collected were the therapeutic groups assessed, the number of TPRs, the time of elaboration, the existence of restrictions versus the authorized indications and the information on the efficiency of medicines. RESULTS: During the period under review, 214 TPRs were carried out, with an average production time of 8.8 months, almost three times the objective of 3-month initially set. 57% of the TPRs established restrictions of use with respect to the approved indications. 26% of TPRs referred to the existence of economic data, although none included details on the efficiency. 10% of TPRs were updated. CONCLUSIONS: For TPRs to meet their objective of improving the efficiency of the assessment process and the consistency in the decisions on price, reimbursement and financing of medicines by the SNS, the deadlines established for publication must be met, incorporating systematically information on the efficiency of the drugs and including periodic updates with the new information generated.
format Online
Article
Text
id pubmed-8054275
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80542752021-04-22 Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019 García, Verónica Corbalán, Laura Baquero, Sandra García-Esquinas, Esther Sacristán, José Antonio Aten Primaria Original OBJECTIVE: Describe the characteristics of the therapeutic positioning reports (TPRs) published in Spain in the period 2013-2019. DESIGN AND DATA SOURCE: Systematic review of all TPRs published in the website of the Spanish Agency of Medicines and Health Products (AEMPS). SELECTION OF STUDIES: All TPRs published since May 2013, until March 2019 DATA EXTRACTION: The main variables collected were the therapeutic groups assessed, the number of TPRs, the time of elaboration, the existence of restrictions versus the authorized indications and the information on the efficiency of medicines. RESULTS: During the period under review, 214 TPRs were carried out, with an average production time of 8.8 months, almost three times the objective of 3-month initially set. 57% of the TPRs established restrictions of use with respect to the approved indications. 26% of TPRs referred to the existence of economic data, although none included details on the efficiency. 10% of TPRs were updated. CONCLUSIONS: For TPRs to meet their objective of improving the efficiency of the assessment process and the consistency in the decisions on price, reimbursement and financing of medicines by the SNS, the deadlines established for publication must be met, incorporating systematically information on the efficiency of the drugs and including periodic updates with the new information generated. Elsevier 2020-12 2020-05-04 /pmc/articles/PMC8054275/ /pubmed/32376055 http://dx.doi.org/10.1016/j.aprim.2020.02.012 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original
García, Verónica
Corbalán, Laura
Baquero, Sandra
García-Esquinas, Esther
Sacristán, José Antonio
Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019
title Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019
title_full Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019
title_fullStr Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019
title_full_unstemmed Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019
title_short Informes de posicionamiento terapéutico: experiencia en España en el periodo 2013-2019
title_sort informes de posicionamiento terapéutico: experiencia en españa en el periodo 2013-2019
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054275/
https://www.ncbi.nlm.nih.gov/pubmed/32376055
http://dx.doi.org/10.1016/j.aprim.2020.02.012
work_keys_str_mv AT garciaveronica informesdeposicionamientoterapeuticoexperienciaenespanaenelperiodo20132019
AT corbalanlaura informesdeposicionamientoterapeuticoexperienciaenespanaenelperiodo20132019
AT baquerosandra informesdeposicionamientoterapeuticoexperienciaenespanaenelperiodo20132019
AT garciaesquinasesther informesdeposicionamientoterapeuticoexperienciaenespanaenelperiodo20132019
AT sacristanjoseantonio informesdeposicionamientoterapeuticoexperienciaenespanaenelperiodo20132019